LifeMD lowers cash-pay price for GLP-1 weight loss medications
Doctor finds new use for GLP-1s: Alcohol, drug addiction | Morning in America
GLP-1 medications have grown popular in recent years for weight loss, but one doctor has found another use: combating alcohol and drug addiction. Dr. Steven Klein, a physician specializing in addiction, joins “Morning in America” to explain more about the pilot program he spearheaded. Start your day with “Morning in America,” NewsNation’s live three-hour national […]
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month – CNBC
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month CNBC Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients Bloomberg.com Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash CNN LifeMD® to Offer Market-Leading Pricing for GLP-1 GlobeNewswire Novo Nordisk rolls out $349 Wegovy cash price ahead of plan Reuters
Growth or Stability? A 2025 Investment Face-Off Between LLY and JNJ
Eli Lilly LLY and Johnson & Johnson JNJ are major U.S. healthcare companies within the pharmaceutical/biotech space. Both companies have a strong presence in oncology, immunology and neuroscience areas. J&J also has drugs for cardiovascular and metabolic diseases, pulmonary hypertension and infectious diseases, along with a strong presence in the medical devices segment. Lilly boasts a […]
Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients – Bloomberg.com
Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients Bloomberg.com Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month CNBC Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash CNN LifeMD® to Offer Market-Leading Pricing for GLP-1 GlobeNewswire Novo Nordisk launches introductory self-pay offer for Wegovy® and Ozempic® for $199 […]
Savile Row boss says weight loss drugs having ‘massive repercussions’ on industry
Among GLP-1 users, more than half said they will eat smaller portions and skip more treats this festive season
Macter gaining market share, and diversifying into cosmetics
Macter International Ltd has emerged from the latest results season with a clear message for investors: momentum is back in branded generics, new biologics are scaling, and a bet on consumer beauty is moving from trial to traction. Management says the company is growing faster than the market, based on data from the healthcare data […]
GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress the need for independent studies before these treatments can be fully embraced worldwide.
Taking Ozempic? Yale Researchers Say You’ll Handle Alcohol “Differently” and It Could Be Risky
GLP-1 drugs may protect the liver but raise blood alcohol levels. Yale researchers are investigating how this dual effect impacts health. Anti-obesity drugs such as semaglutide (Ozempic, Wegovy), are showing potential beyond obesity treatment. Research increasingly suggests that these drugs may help manage alcohol use disorder and alcohol-related liver disease by reducing the desire to […]
Savile Row boss says weight loss drugs are having ‘massive repercussions’ on industry
Among GLP-1 users, more than half said they will eat smaller portions and skip more treats this festive season